ICRF has awarded more than $87 million in funding to support over 2,700 grants to outstanding cancer researchers at all leading institutions in Israel as well as collaborative research partnerships between Israeli and North American investigators. Many of our grantees are responsible for major cancer research breakthroughs and discoveries.

Recipient(s) Institution Grant Type Research Topics Grant Status
Keren Levanon, MD, PhD Chaim Sheba Medical Center The Len & Susan Mark Initiative for Ovarian and Uterine/MMMT Cancers Drug Resistance, Ovarian and Uterine Cancer Active
Dan Levy, PhD Ben-Gurion University of the Negev Project Grant DNA Repair, Genomic Instability Active
Nir London, PhD Weizmann Institute of Science Research Career Development Award Chemical Biology, Drug Discovery, Drug Mechanisms and Development, Medicinal Chemistry, Melanoma, Proteomics and Protein Structures, Skin Cancer Active
Asael Lubotzky, MD Hebrew University of Jerusalem Postdoctoral Fellowship Cancer Metastasis, Clinical and Translational Research, Computational Biology, Genetics and Genomics, Metabolism and Cancer Non-active
Asaf Madi, PhD Tel Aviv University Research Career Development Award Immunology and Immunotherapy, Inflammation and Cancer Active
Ofer Mandelboim, PhD Hebrew University of Jerusalem Research Professorship Grant Immunology and Immunotherapy Active
Yael Mardor, PhD Chaim Sheba Medical Center Acceleration Grant Brain Cancer, Breast Cancer, Metastasis Active
Katy Margulis, PhD Hebrew University of Jerusalem Research Career Development Award Metabolism and Cancer, Skin Cancer Active
David Meiri, PhD Technion, Israel Institute of Technology Project Grant Blood Cancers, Cannabinoids Active
Yifat Merbl, PhD Weizmann Institute of Science ICRF-Cancer Research Institute Clinic and Laboratory Integration Program Grant Immunology and Immunotherapy, Melanoma Active